The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 16 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(30)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
Grizzly Research(1)
Brian Sullivan(1)
https://www.gothamcityresearch.com/
https://www.gothamcityresearch.com/
Current Share Price: 108.360
Gotham City Research LLC
Initial Report Date（2018/09/20）Share Price:208.000
Initial Report Date（2018/09/20）Share Price:208.000
Medifast (NASDAQ: MED): LikeLumber Liquidators, But With Undisclosed Toxic Metals, and A Supply Chain Twist
Details Link > 21% to 74% of Optavia products contain contaminants.
Optavia prices will decline, as prices are 2x
4x more expensive than peers’ products & programs.
Nearly all Optavia products are not manufactured by the
company, contradicting claims otherwise.
MED will be required to add warning labels to its products.
MED’s Optavia products (its “Fuelings”) will require recalls
and/or third-party testing.
Shares will decline 62%-86% the current prices
By wantattse
Subsequent Report （2018/09/27）Share Price:199.152
Medifast (NASDAQ: MED) Part II Optavia Products Are Causing Illness: Irrefutable Evidence
Details Link > Optavia products (its “Fuelings”) are unsafe + cause illness.
10%-25%+ of clients on the flagship 5&1 Plan experience
gastrointestinal or gallbladder-related issues.
Contaminants found in Optavia Fuelings may be causing or
exacerbating health problems.
Optavia Fuelings should be recalled and tested carefully.
We estimate that liability will exceed $60-$100 million.
By wantattse
